Explore / Clinical trial
Clinical trial

Conscious Dying/Conscious Living: Ketamine-Assisted Psychotherapy

The Ketamine Research FoundationUnknownPhase 2Started May 1, 2022120 enrolledNCT05214417

Abstract

The Conscious Dying/Conscious Living study will investigate the effect of KAP (ketamine-assisted psychotherapy) on individuals with terminal illness at five separate geographic locations. Two separate IM ketamine sessions will be administered to 18 subjects at each site, with psychotherapeutic support, including preparatory and integrative sessions. Assessments will be administered throughout the course of the protocol, which will take 4-6 weeks to complete, and the primary outcome measures are changes in the STAI (State-trait Anxiety Inventory, trait assessment only) and the DADDS (Death and Dying Distress Scale) from baseline at the beginning of the study to the conclusion of the treatment period. A six-subject naturalistic comparator group at each site will complete the same assessments without intervention, and then will be offered an optional crossover KAP treatment.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetaminePalliative care

Keywords

ketamine assisted psychotherapyhospicedeath and dyingconscious dyingpsychedelic psychotherapypsychedelicsend of lifelife threatening illnessesIllness Terminal

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.